(Q43075819)

English

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema

scientific article published on 17 December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 November 2017

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema (English)

1 reference

Europe PubMed Central

13 November 2017

author name string

R M Fryer

1

1 reference

Europe PubMed Central

13 November 2017

J Segreti

2

1 reference

Europe PubMed Central

13 November 2017

P N Banfor

3

1 reference

Europe PubMed Central

13 November 2017

D L Widomski

4

1 reference

Europe PubMed Central

13 November 2017

B J Backes

5

1 reference

Europe PubMed Central

13 November 2017

C W Lin

6

1 reference

Europe PubMed Central

13 November 2017

S J Ballaron

7

1 reference

Europe PubMed Central

13 November 2017

B F Cox

8

1 reference

Europe PubMed Central

13 November 2017

J M Trevillyan

9

1 reference

Europe PubMed Central

13 November 2017

G A Reinhart

10

1 reference

Europe PubMed Central

13 November 2017

T W von Geldern

11

1 reference

Europe PubMed Central

13 November 2017

language of work or name

0 references

publication date

17 December 2007

1 reference

Europe PubMed Central

13 November 2017

British Journal of Pharmacology

1 reference

Europe PubMed Central

13 November 2017

153

1 reference

Europe PubMed Central

13 November 2017

5

1 reference

Europe PubMed Central

13 November 2017

947-955

1 reference

Europe PubMed Central

13 November 2017

Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Angiotensin-converting enzyme inhibitor-related angioedema: how to deal with it.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

ACE inhibitors and angiotensin receptor antagonists and the incidence of new-onset diabetes mellitus: an emerging theme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Screening for cardiovascular safety: a structure-activity approach for guiding lead selection of melanin concentrating hormone receptor 1 antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

The kallikrein-kinin system: current and future pharmacological targets.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Human recombinant membrane-bound aminopeptidase P: production of a soluble form and characterization using novel, internally quenched fluorescent substrates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Substance P in the baroreceptor reflex: 25 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Bradykinin and the pathophysiology of angioedema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Omapatrilat. Bristol-Myers Squibb.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Drug-induced angioedema without urticaria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Development of an internally quenched fluorescent substrate selective for endothelin-converting enzyme-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Plasma bradykinin in angio-oedema.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Basic carboxypeptidases: regulators of peptide hormone activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Immunocytochemical localization of endopeptidase-24.11 in the nucleus tractus solitarius of the rat brain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Some old and some new ideas on kinin metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Atrial natriuretic peptide and the baroreflex control of circulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

25 May 2018

Mechanism of vasopeptidase inhibitor-induced plasma extravasation: comparison of omapatrilat and the novel neutral endopeptidase 24.11/angiotensin-converting enzyme inhibitor GW796406.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

15 August 2018

A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

15 August 2018

Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

15 August 2018

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

15 August 2018

Differential tissue and enzyme inhibitory effects of the vasopeptidase inhibitor omapatrilat in the rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

15 August 2018

Bradykinin-mediated angioedema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

15 August 2018

Dual inhibition of angiotensin converting enzyme and neutral endopeptidase by omapatrilat in rat in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

15 August 2018

Cardiovascular effects produced by bradykinin microinjection into the nucleus tractus solitarii of anesthetized rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2267285

15 August 2018

Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tripeptidyl carboxypeptidase activity of kininase II (angiotensin-converting enzyme)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor–induced peritracheal edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angioedema due to angiotensin-converting enzyme inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cleavage of des-Arg9-bradykinin by angiotensin I-converting enzyme from pig kidney cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of UK 69 578: a novel atriopeptidase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of enzymatic processing in the biological actions of substance P

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contributions of various rat plasma peptidases to kinin hydrolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The atriopeptidase inhibitor (±)candoxatrilat reduces the clearance of atrial natriuretic factor in both intact and nephrectomized rats: evidence for an extrarenal site of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum interspecies differences in metabolic pathways of bradykinin and [des-Arg9]BK: influence of enalaprilat

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of aminopeptidase P inhibition on kinin-mediated vasodepressor responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual ACE/NEP inhibitors - more than playing the ACE card

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regional hemodynamic effects of neutral endopeptidase inhibition and angiotensin (AT(1)) receptor antagonism alone or in combination in conscious spontaneously hypertensive rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Bradykinin inhibits carotid sinus baroreflex in anesthetized rats]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18084312

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJP.0707641

1 reference

Europe PubMed Central

13 November 2017

1 reference

Europe PubMed Central

13 November 2017

1 reference

Europe PubMed Central

13 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43075819&oldid=1980108959"